GT Medical Technologies

GammaTile Tile-Based Radiation Therapy for Brain Tumors

United States · Founded 2017 · $100.0M raised

Founded
2017
Business Model
B2B
Total Funding
$100.0M
Last Round
$100.0M Series EJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

GT Medical Technologies is a commercial-stage medical device company headquartered in Tempe, Arizona, that develops GammaTile Therapy, the first and only FDA-cleared tile-based radiation therapy for treating operable brain tumors. Placed directly at the tumor site during surgery, GammaTile is a bioresorbable collagen tile embedded with radiation sources that delivers immediate, targeted radiation to reduce tumor regrowth while protecting healthy brain tissue and limiting side effects such as hair loss. The therapy is FDA-cleared for newly diagnosed and recurrent malignant brain tumors, brain metastases, and recurrent meningiomas, and the company closed an oversubscribed $100 million Series E financing in 2026 to advance commercial adoption.

Summary

GT Medical Technologies is a Healthcare company based in United States, founded in 2017. It has raised $100.0M in total across 1 round, most recently a $100.0M Series E round in Jun 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EJun 2026
$100.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GT Medical Technologies on Indexed.vc
<a href="https://indexed.vc/companies/gt-medical-technologies"><img src="https://indexed.vc/api/badge/company/gt-medical-technologies" alt="GT Medical Technologies on Indexed.vc" width="260" height="76" /></a>